Kiyohiko Hatake

Fas ligand in human serum

Masato Tanaka, Takashi Suda, Kyosuke Haze et al. · Nature Medicine · 1996 · 681 citations

Life Sciences, Biochemistry, Clinical Biochemistry +11

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Youn H. Kim, M. Bagot, Lauren Pinter‐Brown et al. · The Lancet Oncology · 2018 · 645 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma

Michinori Ogura, Takashi Ishida, Kiyohiko Hatake et al. · Journal of Clinical Oncology · 2014 · 361 citations · Full text

Medicine, Oncology, Pharmacology +17

Effect of aging on endothelium-dependent vascular relaxation of isolated human basilar artery to thrombin and bradykinin.

Kiyohiko Hatake, Eizo Kakishita, Ichiro Wakabayashi et al. · Stroke · 1990 · 86 citations · Full text

Medicine, Pharmacology, Physiology +13

Pattern of Tumor Shrinkage during Neoadjuvant Chemotherapy Is Associated with Prognosis in Low-Grade Luminal Early Breast Cancer

Ippei Fukada, Kazuhiro Araki, Kokoro Kobayashi et al. · Radiology · 2017 · 86 citations

Medicine, Oncology, Radiology +15